Literature DB >> 22801904

To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'?

A Ceriello1,2, M Gallo3, S Gentile4, C B Giorda5, A De Micheli6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22801904     DOI： 10.1007/s00125-012-2642-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Finnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatment.

Authors:  A Virkamäki; J Saltevo
Journal:  Diabetologia       Date:  2011-02-18       Impact factor: 10.122

3.  Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach.

Authors:  Antonio Ceriello; Marco Gallo; Vincenzo Armentano; Gabriele Perriello; Sandro Gentile; Alberto De Micheli
Journal:  Diabetes Technol Ther       Date:  2012-01-04       Impact factor: 6.118

4.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

Review 5.  Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders.

Authors:  George L King; Marguerite J McNeely; Lorna E Thorpe; Marjorie L M Mau; Jocelyn Ko; Lenna L Liu; Angela Sun; William C Hsu; Edward A Chow
Journal:  Diabetes Care       Date:  2012-05       Impact factor: 19.112

6.  Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.

Authors:  William H Polonsky; Lawrence Fisher; Charles H Schikman; Deborah A Hinnen; Christopher G Parkin; Zhihong Jelsovsky; Bettina Petersen; Matthias Schweitzer; Robin S Wagner
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 7.  Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications.

Authors:  William C Hsu; Edward J Boyko; Wilfred Y Fujimoto; Alka Kanaya; Wahida Karmally; Andrew Karter; George L King; Mele Look; Gertraud Maskarinec; Ranjita Misra; Fahina Tavake-Pasi; Richard Arakaki
Journal:  Diabetes Care       Date:  2012-05       Impact factor: 19.112
  7 in total
  3 in total

1.  Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.

Authors:  Petra Augstein; Peter Heinke; Lutz Vogt; Roberto Vogt; Christine Rackow; Klaus-Dieter Kohnert; Eckhard Salzsieder
Journal:  BMC Endocr Disord       Date:  2015-05-01       Impact factor: 2.763

2.  Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.

Authors:  Marco Gallo; Edoardo Mannucci; Salvatore De Cosmo; Sandro Gentile; Riccardo Candido; Alberto De Micheli; Antonino Di Benedetto; Katherine Esposito; Stefano Genovese; Gerardo Medea; Antonio Ceriello
Journal:  BMJ Open Diabetes Res Care       Date:  2015-08-12

Review 3.  Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach.

Authors:  Antonio Ceriello; Marco Gallo; Riccardo Candido; Alberto De Micheli; Katherine Esposito; Sandro Gentile; Gerardo Medea
Journal:  Pharmgenomics Pers Med       Date:  2014-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.